Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: OVARIAN NEOPLASMS - GENETICS , . Treffer: 16

2018

Tsibulak, I; Wieser, V; Degasper, C; Shivalingaiah, G; Wenzel, S; Sprung, S; Lax, SF; Marth, C; Fiegl, H; Zeimet, AG BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer.
Br J Cancer. 2018; 119(6):683-692 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Plath, J; Siebenhofer, A; Koné, I; Hechtner, M; Schulz-Rothe, S; Beyer, M; Gerlach, FM; Guethlin, C Frequency of a positive family history of colorectal cancer in general practice: a cross-sectional study.
Fam Pract. 2017; 34(1):30-35 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rashed, MH; Kanlikilicer, P; Rodriguez-Aguayo, C; Pichler, M; Bayraktar, R; Bayraktar, E; Ivan, C; Filant, J; Silva, A; Aslan, B; Denizli, M; Mitra, R; Ozpolat, B; Calin, GA; Sood, AK; Abd-Ellah, MF; Helal, GK; Berestein, GL Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.
Oncotarget. 2017; 8(12):20145-20164 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Zeimet, AG; Mori, H; Petru, E; Polterauer, S; Reinthaller, A; Schauer, C; Scholl-Firon, T; Singer, C; Wimmer, K; Zschocke, J; Marth, C AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS).
ARCH GYNECOL OBSTET. 2017; 296(1): 123-127. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Endris, V; Stenzinger, A; Pfarr, N; Penzel, R; Möbs, M; Lenze, D; Darb-Esfahani, S; Hummel, M; Sabine-Merkelbach-Bruse, M; Jung, A; Lehmann, U; Kreipe, H; Kirchner, T; Büttner, R; Jochum, W; Höfler, G; Dietel, M; Weichert, W; Schirmacher, P NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial.
Virchows Arch. 2016; 468(6):697-705
Web of Science PubMed FullText FullText_MUG

 

Kanlikilicer, P; Rashed, MH; Bayraktar, R; Mitra, R; Ivan, C; Aslan, B; Zhang, X; Filant, J; Silva, AM; Rodriguez-Aguayo, C; Bayraktar, E; Pichler, M; Ozpolat, B; Calin, GA; Sood, AK; Lopez-Berestein, G Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.
Cancer Res. 2016; 76(24):7194-7207 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Marth, C; Hubalek, M; Petru, E; Polterauer, S; Reinthaller, A; Schauer, C; Scholl-Firon, T; Singer, CF; Zschocke, J; Zeimet, AG AGO Austria recommendations for genetic testing of patients with ovarian cancer.
Wien Klin Wochenschr. 2015; 127(15-16):652-654 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2013

Tea, MK; Weghofer, A; Wagner, K; Singer, CF Association of BRCA1/2 mutations with FMR1 genotypes: effects on menarcheal and menopausal age.
Maturitas. 2013; 75(2):148-151
Web of Science PubMed FullText FullText_MUG

 

2011

Kriegshäuser, G; Auner, V; Schuster, E; Holzer, B; Oberkanins, C; Horvat, R; Speiser, P; Zeillinger, R KRAS mutation analysis in genomic DNA isolated from formalin-fixed paraffin-embedded ovarian tissue: evaluation of a strip-based reverse-hybridisation assay.
J Clin Pathol. 2011; 64(3): 252-256.
Web of Science PubMed FullText FullText_MUG

 

2010

Pristauz, G; Geigl, JB; Petru, E BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer.
Wien Med Wochenschr. 2010; 160(7-8): 158-162.
PubMed FullText FullText_MUG

 

2009

Auner, V; Kriegshäuser, G; Tong, D; Horvat, R; Reinthaller, A; Mustea, A; Zeillinger, R KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay.
BMC Cancer. 2009; 9(1): 111-111. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2007

Agic, A; Xu, H; Altgassen, C; Noack, F; Wolfler, MM; Diedrich, K; Friedrich, M; Taylor, RN; Hornung, D Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers.
Reprod Sci. 2007; 14(5): 486-497.
Web of Science PubMed FullText FullText_MUG

 

2005

Kroiss, R; Winkler, V; Bikas, D; Fleischmann, E; Mainau, C; Frommlet, F; Muhr, D; Fuerhauser, C; Tea, M; Bittner, B; Kubista, E; Oefner, PJ; Bauer, P; Wagner, TM; Austrian Hereditary Breast and Ovarian Cancer Group Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers.
Hum Mutat. 2005; 26(6): 583-589.
Web of Science PubMed FullText FullText_MUG

 

2001

Manavi, M; Bauer, M; Baghestanian, M; Berger, A; Kucera, E; Pischinger, K; Battistutti, W; Czerwenka, K Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium.
Tumour Biol. 2001; 22(5):299-309
Web of Science PubMed FullText FullText_MUG

 

1999

Vlasak, I; Plöchl, E; Kronberger, G; Bergendi, E; Rittinger, O; Hagemann, M; Schmitt, K; Blümel, P; Glatzl, J; Fekete, G; Kadrnka-Lovrencic, M; Borkenstein, M; Häusler, G; Frisch, H Screening of patients with Turner syndrome for hidden Y-mosaicism.
Klin Padiatr. 1999; 211(1):30-34
Web of Science PubMed FullText FullText_MUG

 

Wagner, TM; Hirtenlehner, K; Shen, P; Moeslinger, R; Muhr, D; Fleischmann, E; Concin, H; Doeller, W; Haid, A; Lang, AH; Mayer, P; Petru, E; Ropp, E; Langbauer, G; Kubista, E; Scheiner, O; Underhill, P; Mountain, J; Stierer, M; Zielinski, C; Oefner, P Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.
Hum Mol Genet. 1999; 8(3):413-423 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum